Study guide
17.4 Hormones, Receptors, Second Messengers & Signal Transduction
APMLE Part I Basic Sciences Podiatry
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Lower Extremity Osteology
1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics
2 Chapter 2: Lower Extremity Arthrology & Ligaments
2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics
3 Chapter 3: Lower Extremity Myology & Compartments
3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations
4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy
4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces
5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology
6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods
7 Chapter 7: General & Cellular Pathology
7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors
8 Chapter 8: Systemic & Podiatric Pathology
8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation
9 Chapter 9: Organ-System Pathology
9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology
10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology
10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology
11 Chapter 11: Antimicrobial & Podiatric Therapeutics
11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology
12 Chapter 12: Systemic Pharmacology
12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents
13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy
13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways
14 Chapter 14: Histology, Integument, Embryology & Genetics
14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging
15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology
15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics
16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood
16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology
17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling
17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction
18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition
18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals
17.4 Hormones, Receptors, Second Messengers & Signal Transduction
Key Takeaways Explain This Topic AI
Water-soluble peptide and catecholamine hormones act on cell-surface receptors through second messengers, while lipid-soluble steroid and thyroid hormones (and vitamin D) bind intracellular nuclear receptors that act as transcription factors.
Gs-coupled receptors raise cAMP and activate protein kinase A, Gi-coupled receptors lower cAMP, and Gq-coupled receptors activate phospholipase C to produce IP3 (calcium release) and DAG (protein kinase C).
Insulin and growth factors (PDGF, EGF, FGF, VEGF, IGF-1) signal through receptor tyrosine kinases, cytokines through JAK-STAT, TGF-beta through serine/threonine kinase receptors and SMADs, and nitric oxide and natriuretic peptides through cGMP.
Cholera toxin ADP-ribosylates Gs alpha (locking it active), pertussis toxin ADP-ribosylates Gi alpha (blocking inhibition), and both raise cAMP.
Only free (unbound) hormone is active; plasma transport proteins such as thyroxine-binding globulin, cortisol-binding globulin and sex hormone-binding globulin change total but not free hormone levels.
Last updated: October 2026
17.4 Hormones, Receptors, Second Messengers & Signal Transduction
The biochemistry outline lists hormones, second messengers and signal transduction , with subtopics of growth factors, receptors, steroids and thyroid hormones, plasma transport proteins and glucose-regulating hormones. Endocrine gland physiology is in 16.3. This section explains the molecular signaling those hormones and many drugs use, including beta-agonists, insulin, phosphodiesterase inhibitors, JAK inhibitors and corticosteroids.
Hormone Classes
Class Examples Solubility and transport Receptor location Speed
Peptide and protein Insulin, glucagon, PTH, ACTH, growth hormone Water-soluble; mostly free in plasma Cell surface Seconds to minutes
Amine (catecholamine) Epinephrine, norepinephrine, dopamine Water-soluble Cell surface Seconds
Amine (thyroid) T4, T3 Lipid-soluble; bound to TBG, transthyretin, albumin Nuclear (thyroid hormone receptor with RXR) Hours to days
Steroid Cortisol, aldosterone, estrogen, testosterone, calcitriol Lipid-soluble; bound to carrier proteins Cytoplasmic or nuclear Hours
Eicosanoids Prostaglandins, thromboxanes, leukotrienes Local (paracrine) Cell surface G-protein-coupled receptors Seconds
Plasma transport proteins. Only the free fraction binds receptors and is cleared. Cortisol-binding globulin (transcortin), sex hormone-binding globulin, thyroxine-binding globulin (TBG) and albumin act as reservoirs. Estrogen (pregnancy, oral contraceptives) raises TBG , which increases total T4 while free T4 stays normal, so free hormone levels are the ones to interpret.
G-Protein-Coupled Receptors
GPCRs have seven transmembrane helices and couple to heterotrimeric G proteins (alpha, beta and gamma subunits). Ligand binding causes the alpha subunit to exchange GDP for GTP and separate from beta-gamma. The alpha subunit's own GTPase activity ends the signal.
G protein Effector Second messenger Representative receptors
Gs Activates adenylyl cyclase Increased cAMP , which activates protein kinase A Beta-1, beta-2, D1, H2, V2, glucagon, PTH , TSH, ACTH, FSH, LH, calcitonin, GHRH
Gi Inhibits adenylyl cyclase Decreased cAMP ; opens K+ channels Alpha-2, M2, D2, opioid receptors
Gq Activates phospholipase C IP3 (releases Ca2+ from the ER) and DAG (activates protein kinase C ) Alpha-1, M1, M3, H1, V1, AT1, GnRH, TRH, oxytocin, gastrin
Phosphodiesterases (PDEs) degrade cAMP and cGMP. Inhibitors amplify these signals:
- Theophylline and caffeine (nonselective)
- Cilostazol (PDE3) for claudication
- Roflumilast (PDE4) for COPD
- Sildenafil (PDE5) for erectile dysfunction
Bacterial toxins also target G proteins:
Cholera toxin ADP-ribosylates Gs alpha , which locks it in the GTP-bound active state; cAMP rises and intestinal chloride secretion causes watery diarrhea.
Pertussis toxin ADP-ribosylates Gi alpha , which prevents inhibition of adenylyl cyclase, so cAMP also rises.
cGMP Signaling
Soluble guanylyl cyclase is activated by nitric oxide (endothelial NO, nitroglycerin and nitroprusside). It raises cGMP and protein kinase G activity, causing smooth muscle relaxation and vasodilation.
Membrane (particulate) guanylyl cyclase is the receptor for ANP and BNP , which cause natriuresis and vasodilation.
Enzyme-Linked Receptors
Receptor class Ligands Pathway Clinical connection
Receptor tyrosine kinases Insulin , IGF-1, PDGF , EGF , FGF , VEGF , NGF Ligand-induced dimerization and autophosphorylation; insulin acts through IRS-1, then PI3K/Akt (GLUT4 translocation, glycogen synthesis) and Ras/MAPK (growth) Insulin resistance; becaplermin (PDGF) for ulcers; EGFR and VEGF inhibitors in cancer (12.4)
Non-receptor tyrosine kinase (JAK-STAT) Cytokines (IL-2, IL-6, interferons), growth hormone , prolactin, erythropoietin , G-CSF, thrombopoietin Receptor-associated JAKs phosphorylate STATs, which dimerize and enter the nucleus JAK inhibitors (tofacitinib) in RA; JAK2 V617F in polycythemia vera (9.1)
Serine/threonine kinase receptors TGF-beta , bone morphogenetic proteins Phosphorylate SMAD proteins TGF-beta drives fibrosis and wound matrix; BMPs drive bone formation (bone graft substitutes)
Ligand-gated ion channels Acetylcholine (nicotinic), GABA-A, glutamate Direct ion flux Neuromuscular blockers, benzodiazepines
Growth factors in tissue repair. PDGF (platelets, macrophages) recruits fibroblasts and smooth muscle cells. VEGF drives angiogenesis in granulation tissue. FGF-2 supports angiogenesis and fibroblast proliferation. EGF and KGF stimulate re-epithelialization. TGF-beta stimulates collagen synthesis and myofibroblast contraction (7.2).
Nuclear (Intracellular) Receptors
Lipophilic ligands cross the membrane and bind receptors that act as ligand-activated transcription factors at hormone response elements in DNA:
Glucocorticoid receptor: cytoplasmic and held by HSP90. After ligand binding it moves to the nucleus to induce genes such as annexin A1 (lipocortin) and to repress NF-kB-driven genes (11.3).
Mineralocorticoid, estrogen, progesterone and androgen receptors.
Thyroid hormone, vitamin D (VDR), retinoic acid and PPAR receptors , which partner with RXR . PPAR-gamma is the target of pioglitazone (12.2).
Steroid and Thyroid Hormone Synthesis
Steroids are made from cholesterol . Delivery of cholesterol to the inner mitochondrial membrane by StAR and cleavage by side-chain cleavage enzyme (CYP11A1, desmolase) to pregnenolone are the rate-limiting steps, stimulated by ACTH (adrenal) or LH (gonads). 21-hydroxylase deficiency , the most common form of congenital adrenal hyperplasia, lowers cortisol and aldosterone and shunts precursors into androgens. Calcitriol, the secosteroid form of vitamin D, is covered in 16.3.
Thyroid hormones: iodide is trapped by the Na+/I- symporter, then oxidized and attached to thyroglobulin tyrosines by thyroid peroxidase (blocked by methimazole and propylthiouracil). Coupling forms T4 and T3. Peripheral 5'-deiodinase converts T4 to the more active T3 ; PTU and high-dose glucocorticoids inhibit this step.
Glucose-Regulating Hormones
Insulin secretion by the beta cell:
Glucose enters through GLUT2 and is phosphorylated by glucokinase , the glucose sensor.
The rising ATP/ADP ratio closes K-ATP channels (the target of sulfonylureas, 12.2).
Membrane depolarization opens voltage-gated Ca2+ channels .
Calcium influx triggers insulin exocytosis. Incretins (GLP-1, GIP) amplify secretion through Gs and cAMP.
Insulin actions: glucose uptake through GLUT4 in muscle and fat, glycogen and fat synthesis, protein synthesis, potassium uptake into cells, and inhibition of lipolysis, ketogenesis and hepatic glucose output.
Counterregulatory hormones:
- Glucagon (Gs and cAMP in the liver): glycogenolysis, gluconeogenesis, ketogenesis
- Epinephrine (beta-2 and alpha): glycogenolysis, lipolysis, suppression of insulin through alpha-2
- Cortisol: gluconeogenesis, insulin resistance; it is permissive for glucagon and catecholamine effects
- Growth hormone: lipolysis and insulin resistance
These counterregulatory hormones explain stress hyperglycemia after trauma, surgery or infection and why corticosteroid injections or systemic courses raise glucose in people with diabetes for several days.
Signal Termination and Desensitization
Signals stop through GTP hydrolysis, phosphodiesterases and phosphatases. With repeated stimulation, GPCR kinases and beta-arrestin uncouple and internalize receptors (desensitization and downregulation). This explains tachyphylaxis to repeated beta-agonist doses and the rebound effects after withdrawing a receptor blocker (10.3).